---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-25-002210"
form_type: "8-K"
ticker: "ARTL"
cik: "0001621221"
company_name: "ARTELO BIOSCIENCES, INC."
filed_at: "2025-11-25T23:59:59+00:00"
generated_at: "2026-05-16T16:55:47.229551+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Artelo Biosciences receives Nasdaq delisting notice; plans to appeal

## Summary
- Received delist determination on Nov 19, 2025 for non-compliance with equity rule (min $2.5M stockholders' equity).
- Submitted compliance plans on July 7 and Aug 29, 2025, but did not complete the planned capital raise.
- Unless appeal requested by Nov 26, delisting effective Dec 1, 2025; intends to appeal to Nasdaq hearing panel.
- Stock (ARTL) continues trading on Nasdaq during appeal process.

## SEC filing metadata
- accession: 0001640334-25-002210
- form_type: 8-K
- ticker: ARTL
- cik: 0001621221
- company_name: ARTELO BIOSCIENCES, INC.
- filed_at: 2025-11-25T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1621221/000164033425002210/0001640334-25-002210-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1621221/000164033425002210/artl_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-25-002210
- JSON: https://secwatch.observer/filing/0001640334-25-002210.json
- Plain text: https://secwatch.observer/filing/0001640334-25-002210.txt

## Source-grounded claims
- claim_id: c74063c18679d1b7e82a7f75cf8289b4dec6de27
  claim: ARTELO BIOSCIENCES, INC. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(1)).
  evidence_excerpt: ndicated that unless the Company requests a hearing panel appeal of the delist determination by November 26, 2025, its securities would be delisted on December 1, 2025. The Company intends to appeal Nasdaq’s determination to a hearing panel pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series to stay any further delisting actions through the hearing or any extension the hearings panel provides. Following the appeal request, the Company’s common stock, par value $0.001 per share, will continue to trade on Nasdaq under the symbol “ARTL.” 2 SIGNATURES Pursuant to the requir
  evidence_url: https://www.sec.gov/Archives/edgar/data/1621221/000164033425002210/0001640334-25-002210-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.